Lymphoid Malignancies Branch
We combine basic research, preclinical investigation, and drug development with innovative, therapeutic clinical trials to treat lymphoid malignancies.
Related Articles
ESH – European School of Haematology
7th Translational Research ConferenceLymphoid MalignanciesOctober 20-22, 2023 – Estoril, Portugal #ESHLYMPHOID2023 Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt REGISTRATION & ABSTRACT SUBMISSION ARE…
Please wait whilst we redirect you
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing…
Burkitt’s Lymphoma | NEJM
Review Article from The New England Journal of Medicine — Burkitt’s Lymphoma
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma
Key Points. MCD-associated genetic lesions strongly promoted accumulation of B cells in splenic germinal centers (GCs) of unimmunized miceMice engineered to har
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA – Nature Biotechnology
The sensitivity of circulating tumor DNA detection is improved by identifying sequences with two or more mutations.
RNA Biology Laboratory
We conduct cutting-edge research into the roles of RNAs and RNA protein complexes in cancer.
Clinical trial evaluates COVID-19 vaccine in adults in treatment for cancer
Adults with hematologic malignancies or solid tumors may be eligible to participate in a new clinical trial at the NIH Clinical Center. Elad Sharon, M.D.,…
NCI-CONNECT – Comprehensive Oncology Network Evaluating Rare CNS Tumors
Comprehensive Oncology Network Evaluating Rare CNS Tumors NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) aims to advance the understanding of rare adult central nervous…
